Mackay Shields’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Mackay Shields's ABBV Position: Q2 2022 in Review
Mackay Shields sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 254,342 shares — an estimated $41.2M sold.
Mackay Shields first reported a position in ABBV in Q1 2018 and held it in 17 quarters. The position peaked at $69.3M in Q1 2018. 3,008 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.
- Mackay Shields reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
- Mackay Shields sold 254,342 AbbVie shares in Q2 2022, an estimated $41.2M.
- Mackay Shields first reported a position in AbbVie in Q1 2018 and held it in 17 quarters.
- Mackay Shields's AbbVie position peaked at $69.3M in Q1 2018.
- 3,008 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.
Based on Mackay Shields's 13F filing for Q2 2022, filed 3 Aug 2022.